Biocon recalls 3,665 bottles of antifungal drug in U.S. for failed degradation specifications
As per the U.S. FDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in […]
Continue Reading
